InMode Ltd.

INMD

IL0011595993

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 01:30:00 18/07/2024 am IST			5-day change	1st Jan Change
18.72 ^USD	-1.78%		+6.67%	-15.83%

17/07	InMode Says FDA Clears Morpheus8 Technology for Soft Tissue Contraction	MT
17/07	InMode Ltd. Announces an Additional FDA 510(K) Clearance for the Morpheus8 Technology	CI

InMode Ltd. Provides Revenue Guidance for the Full Year of 2021

January 12, 2021 at 06:30 pm IST

InMode Ltd. provided revenue guidance for the full year of 2021. Full year 2021 revenue guidance in the range of $250 million to $260 million.

Latest news about InMode Ltd.

InMode Says FDA Clears Morpheus8 Technology for Soft Tissue Contraction	17/07	MT
InMode Ltd. Announces an Additional FDA 510(K) Clearance for the Morpheus8 Technology	17/07	CI
Barclays Lowers Price Target on InMode to $29 From $33, Maintains Overweight Rating	15/07	MT
Canaccord Genuity Adjusts InMode's PT to $16 From $21, Keeps Hold Rating	12/07	MT
InMode Ltd. Provides Revenue Guidance for the Second Quarter and Full Year 2024	11/07	CI
InMode Ltd.(NasdaqGS:INMD) added to Russell Small Cap Comp Value Index	01/07	CI
InMode Ltd.(NasdaqGS:INMD) added to Russell 3000 Value Index	01/07	CI
InMode Ltd.(NasdaqGS:INMD) added to Russell 2500 Value Index	01/07	CI
InMode Ltd.(NasdaqGS:INMD) added to Russell 2000 Value Index	01/07	CI
InMode Ltd.(NasdaqGS:INMD) added to Russell 2000 Value-Defensive Index	01/07	CI
InMode Ltd.(NasdaqGS:INMD) added to Russell 3000E Value Index	01/07	CI
UBS Adjusts Price Target on InMode to $20 From $26, Maintains Neutral Rating	03/05	MT
InMode Shares Rise; Q1 Non-GAAP Earnings, Revenue Fall; 2024 Guidance Cut	02/05	MT
Transcript : InMode Ltd., Q1 2024 Earnings Call, May 02, 2024	02/05
Earnings Flash (INMD) INMODE Posts Q1 EPS $0.32, vs. Street Est of $0.41	02/05	MT
InMode Ltd. Announces Chairman Changes, Effective on July 25, 2024	02/05	CI
InMode Ltd. announces an Equity Buyback for 8,370,000 shares.	02/05	CI
InMode Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	02/05	CI
InMode Ltd. Revises Earnings Guidance for the Full Year Ending December 31, 2024	02/05	CI
InMode Ltd. authorizes a Buyback Plan.	01/05	CI
Barclays Adjusts Price Target on InMode to $33 From $34, Maintains Overweight Rating	12/04	MT
Sector Update: Health Care Stocks Edge Higher Pre-Bell Tuesday	09/04	MT
InMode Lowers Fiscal 2024 Revenue Forecast, Issues Fiscal Q1 Guidance	09/04	MT
Inmode Ltd. Provides Revenue Guidance for the First Quarter of 2024	09/04	CI
Glass Lewis Issues Shareholders Alert on InMode Ahead of Annual Meeting	21/03	MT

Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and womenâs health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.

Sector

Advanced Medical Equipment & Technology

Calendar

01/08/2024 - Q2 2024 Earnings Release

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for InMode Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

18.72 USD

Average target price

21.6 USD

Spread / Average Target

+15.38%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
INMODE LTD.	-15.83%	158.41Cr
THERMO FISHER SCIENTIFIC	+4.57%	21TCr
DANAHER CORPORATION	+8.61%	19TCr
INTUITIVE SURGICAL, INC.	+26.34%	15TCr
BOSTON SCIENTIFIC CORPORATION	+33.90%	11TCr
SIEMENS HEALTHINEERS AG	+2.24%	6.56TCr
EDWARDS LIFESCIENCES CORPORATION	+14.50%	5.26TCr
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-3.30%	4.68TCr
AGILENT TECHNOLOGIES, INC.	-3.98%	3.9TCr
GE HEALTHCARE TECHNOLOGIES INC.	+6.66%	3.76TCr

Other Advanced Medical Equipment & Technology

InMode Ltd.

Equities

INMD

IL0011595993

Advanced Medical Equipment & Technology

InMode Ltd. Provides Revenue Guidance for the Full Year of 2021

Latest news about InMode Ltd.

Chart InMode Ltd.

Company Profile

Income Statement Evolution

Ratings for InMode Ltd.

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Advanced Medical Equipment & Technology